WHO ICTRP trial
Effect of liraglutide or glimepiride added to metformin on blood glucose control…
CTRI/2008/091/000014 · Clinical Trials Registry India (CTRI) · Not Recruiting
Key facts
| Trial ID | CTRI/2008/091/000014 |
|---|---|
| Public title | Effect of liraglutide or glimepiride added to metformin on blood glucose control in subjects with type 2 diabetes |
| Scientific title | Effect of liraglutide or glimepiride added to metformin on glycaemic control in subjects with type 2 diabetes |
| Primary sponsor | Novo Nordisk AS |
| Registry | Clinical Trials Registry India (CTRI) |
| Recruitment status | Not Recruiting |
| Study type | Interventional |
| Phase | Phase 3 |
| Countries | India;China;Democratic People's Republic of Korea |
| Conditions | Health Condition 1: null- Diabetes Mellitus, Type 2 |
| Interventions | Intervention1: B (Experimental): Drug: placebo. Glimepiride placebo, capsulesDrug: liraglutide. Drug: metformin. Tablets: 1.2 mg/day, s.c. injection Intervention2: A (Experimental): Drug: liraglutide. Drug: placebo. Glimepiride placebo… |
| Registration date | Mar 27, 2008 |
| Target size | 896 |
| Secondary IDs | NCT00614120;NN2211-1796 |
| Registry page | ctri.nic.in |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: